Use of abdominal drain is a tradition used since a long time. These is generally done to prevent or drain any post-operative intra-abdominal collection aiming to reduce morbidity and mortality and early recovery of patient. But drain has its own complication such as drain site infection, drain site hernia. We encountered a case of bilateral drain site hernia in a 55 year old female who was previously operated for perforation peritonitis. Both herniae were repaired successfully with onlay meshplasty. Drain placement has various complications like drain site infection, adhesion's, intestinal erosion, bleeding, anastamotic rupture and drain site hernia. There is greater risk of hernia in patient with poor nutritional status, obesity, ascitis, severe abdominal infection or with persistent cough. It is better to avoid unnecessary placement of drain. If a drain is placed, its removal should be done as early as possible. It is better to close the defect after removal of drain.
Background: Colorectal cancers are third most commonly diagnosed cancer globally. Its management consist mainly of surgical intervention to achieve an oncologic cure but also to preserve function. Introduction of nerve-preserving TME technique, spares the nerve and plexus pivotal for urinary and sexual function. The study assessed the urinary and sexual function after nerve sparing colorectal surgery. Aims and objective were to check functional outcomes after nerve preservation in patient undergoing colorectal cancer surgery, in terms of urinary and sexual function.Methods: A prospective observational study conducted from January 2019 to July 2020, in the department of surgery and oncosurgery, Dr. BRAM Hospital, Raipur, Chhattisgarh.Results: According to IPSS score, post-operatively, 57.5% showed fair urinary function, 22.5% showed good urinary function and 20% showed poor urinary function at 1 month. At 3 months, 80% showed good urinary function, 15% showed fair urinary function and 5% showed poor urinary function. According to IIEF score in males, post-operatively, at 1 month, 52% had a fair score, 40% had a poor score and 8% had a good score. At 3 months, 68% had a good score, 24% had a fair score and 8% had a poor score. According to FSFI score in females, post-operatively, at 1 month, 40% had a good score, 26.6% had fair score and 33.33% had a poor score. At 3 months, 66.67% had a good score, 13.33% had a fair score and 20% had a poor score.Conclusions: Nerve preserving surgery in colorectal cancer significantly preserves urinary and sexual function.
Introduction There is no consensus on the optimal surgery for splenic flexure cancers. Methods Review of a prospectively maintained database of patients with splenic flexure cancer undergoing either a right extended hemicolectomy or left hemicolectomy at a tertiary care cancer hospital from 14.5.2010 to 16.9.2021. The primary outcome measures were postoperative morbidity and hospital stay with secondary outcomes being overall survival, disease free survival and long-term patient reported functional and quality of life outcomes. Results The demographic variables were evenly distributed between groups and median follow up was 44 months. The groups were comparable in terms of postoperative morbidity (Clavien-Dindo complication ³3a 10.6% Vs 10%, p=0.322) and hospital stay (8 days Vs 7 days, p=0.316). Oncological outcomes were similar in both groups (3-year DFS 71.8% Vs 67.8% p = 0.877 and 3-year OS 83.9% Vs 75.8%, p=0.787) and long-term patient reported functional outcomes were excellent in both groups. Conclusion Oncological outcomes, post operative morbidity and long-term patient reported functional outcomes are comparable in patients undergoing either a right extended or left hemicolectomy for splenic flexure cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.